Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. [electronic resource]
Producer: 20040427Description: 385-92 p. digitalISSN:- 0893-133X
- Adolescent
- Adult
- Antidepressive Agents -- therapeutic use
- Depressive Disorder, Major -- drug therapy
- Double-Blind Method
- Drug Evaluation
- Drug Tolerance
- Female
- Humans
- Male
- Middle Aged
- Neurokinin-1 Receptor Antagonists
- Personality Inventory
- Psychiatric Status Rating Scales
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.